Sara Cacciapuoti

14PUBLICATIONS
23CO-AUTHORS
Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersPharmacogenomicsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 13, 2024
Short-term efficacy of tildrakizumab on difficult-to-treat areas: a real-world experience.

Sara Cacciapuoti, Luca Potestio, Lucia Gallo

|May 11, 2024
Real-Life Effectiveness and Safety of Guselkumab in Patients with Psoriasis Who Have an Inadequate Response to Ustekinumab: A 3-Year Multicenter Study.

Matteo Megna, Anna Balato, Stefano Caccavale

|Apr 13, 2024
Biological Therapy for Psoriasis in Cancer Patients: An 8-Year Retrospective Real-Life Study.

Teresa Battista, Lucia Gallo, Fabrizio Martora

|Aug 26, 2023
New Onset and Exacerbation of Psoriasis Following COVID-19 Vaccination: A Review of the Current Knowledge.

Luca Potestio, Teresa Battista, Sara Cacciapuoti

|May 13, 2023
Long-Term Efficacy and Safety of Risankizumab for Moderate to Severe Psoriasis: A 2-Year Real-Life Retrospective Study.

Matteo Megna, Angelo Ruggiero, Teresa Battista

|Jul 27, 2022
Lymphocyte Population Changes at Two Time Points during the Acute Period of COVID-19 Infection.

Giulia Scalia, Maddalena Raia, Monica Gelzo

Pageof 3

Frequent Collaborators

9 joint publications

Matteo Megna

5 joint publications

Luca Potestio

4 joint publications

Ivan Gentile

4 joint publications

Angelo Ruggiero